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Abstract
A low native membrane permeability and ineffective access to the cellular cytosol, together with 
aggressive proteolytic degradation, often severely hampers the practical application of any 
therapeutic protein or antibody. Through engineering the charging profile of mesoporous silica 
nanoparticles, cellular uptake and subsequent subcellular distribution can be controlled. We show 
herein that programmed cell death can subsequently be induced across a population of cancer cells 
with remarkable efficacy on conjugating a specific caspase-cascade-activating cytochrome to such 
cytosol-accessing particles.
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Introduction
The ability to deliver functionally competent proteins or nucleic acids into live cells 
constitutes a potentially hugely powerful therapeutic modality.[1] Combatting inherent poor 
cellular permeability and proteolytic degradation[1] has, however, been challenging. A 
number of methods have been employed, with varying degrees of success, in overcoming 
both the physical barrier presented by the cell membrane and the chemical barrier presented 
by cell internal protease. These have included chemical or biological modifications to 
increase affinity for membrane transport proteins or the cell membrane itself,[2] and the 
utilisation of nanoparticles,[2b,3] with the latter approach being suggested to be particularly 
beneficial in protecting supported biomolecules from proteolytic degradation.[2b,3a,b,4]
During the past decade, numerous studies have examined the interactions of nanoparticles, 
including those based on a silica scaffold, with live cells.[5] From this, it has generally 
become acknowledged that nanoparticles are taken up through endocytosis and that the 
involvement of acidic endosomes/lysosomes, central in cellular degradation of foreign 
material, is characteristic.[6] In the vast majority of cases, particles taken up in this way are 
subsequently trapped within these compartments, unable to access the cytoplasm or nucleus 
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or to directly influence cellular physiology.[7] From either gene transfection or protein 
delivery perspectives, payload access to the cytosol is a requirement;[7a,8] therefore, a 
number of approaches have been examined to facilitate the escape of nanoparticles or 
therapeutic agents from this default and highly acidic endo/lysosomal pathway.[2c,3a,9] In 
many cases this has been through engineering destructive or penetrating interactions with 
the endosome/lysosome membrane.[9b,10] An alternative approach based on a pH-buffering 
(“proton sponge”) effect has also been proposed and employed with some degree of success 
with inorganic nanoparticles.[9c,11] The effect is mediated by agents with high buffering 
capacities (chemically these contain weak basic amine-derived functional groups, such as 
quinoline,[3a] imidazole[9a,11b] or tertiary amines[9c]) capable of soaking up protons and 
generating a difference in osmotic pressure between endosomes and the cytosol. The 
subsequent influx of ions and water leads to endosomal membrane rupturing.[9d] Though the 
effectiveness of these approaches has been increasingly utilised, an understanding of the key 
design or mechanistic criteria has generally been lacking. We have sought, in the first 
instance here, to systematically investigate and then propose a more universal means of 
enabling endo/lysosomal escape, facilitating payload access to the cell cytosol.
Apoptosis, defined by characteristic nuclear morphology change (including chromatin 
condensation and fragmentation), overall cell shrinkage and the formation of apoptotic 
bodies, is distinguished from innate cell death (necrosis) by a programmed collapse of 
cellular infrastructure through proteolytic digestion by members of the caspase family of 
proteases.[12] A dominant route to triggering this programmed cell death involves the 
mitochondrial pathway, in which the release of “cytochrome c” into the cytosol and the 
subsequent activation of a caspase cascade is characteristic.[8] There have been, accordingly, 
several studies in which attempts have been made to directly deliver this small, membrane-
impermeable protein to live cells using various vehicles.[2b,3a,b,4a,13] In some cases 
apoptosis has been noted,[2b,3a,13a] although this has been by no means a consistent 
observation.[3b,4a,13b] Attempts using silica nanoparticles as delivery systems for this 
protein, thus far, have been entirely without indication of cell death.[3b,4a] The aim of this 
work was to engineer nanoparticle scaffolds capable of reliably escaping into the cellular 
cytosol once taken up by live cells. These same particles were to then be surface modified 
with cytochrome c without disruption of endo/lysosomal escaping capacity in the hope that 
they could induce effective and characterised apoptotic cell death (unprecedented for 
particles of this type). Finally, the importance of nanoparticle retention of the cytochrome, 
as opposed to its release, was to be assessed from a triggered cell-killing perspective.
Results and Discussion
Engineering endo/lysosomal escape
In order to effectively induce programmed cell death, it was initially necessary to design 
nanoparticles ultimately capable of reproducibly accessing the cellular cytoplasm. 
Significantly, though “proton-sponge effects” have been previously utilised, the associated 
chemistry is commonly cytotoxic,[14] and the significance of particle charging profile 
neither recognised nor examined. Herein, we start by preparing a range of mesoporous silica 
nanoparticles (MSNs) generated by a typical surfactant-templated and base-catalysed 
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procedure.[15] MSNs were selected as the scaffold herein due to their convenient high 
surface area silanol surface modification and potential utility in further multimodal work. 
Surface modification and their ability to escape endo/lysosomal entrapment were 
investigated systematically. Particle distribution, stability, size and morphology, and the 
retention of these characteristics across all chemical and biological modifications was 
characterised by dynamic light scattering (DLS) and transmission electron microscopy 
(TEM; see Figure 1). The native luminescent MSNs were prepared by co-condensing 
tetraethyl orthosilicate (TEOS) and aminopropyltriethoxysilane (APTES) with templating 
cetyltrimethylammonium bromide (CTAB). The as-synthesised internally aminated MSNs 
were subsequently coupled with N-hydroxysuccinimide (NHS)-fluorescein to obtain 
internally luminescent MSNs where the unmodified external surfaces remain accessible for 
subsequent amine grafting and bio-functionalisation (FITC-MSNs, type (1); Figure 1). 
These constructs were then selectively modified with primary amines or imidazole 
functionalities. In the first instance, nanoparticle cytosol access was optimised through the 
mol% and pKa of amine groups post-grafted onto the MSNs. In order to initially consider the 
effects of functional group surface concentration, three different mol% (with respect to 
TEOS) of external primary amine modified luminescent MSNs were produced (namely 1 
mol%, 5 mol% and 10 mol%) and designated as types (2)a, (2)b and (2)c, respectively 
(Figure 1). The cellular uptake characteristics (24 h incubations with human cervical 
carcinoma HeLa cells) of these are shown in the confocal images of Figure 2 and Figure S1 
in the Supporting Information, which are representative of behaviour observed across the 
cell population. All three particle samples were reliably internalised within this timeframe 
by endocytosis. Although mitosis of HeLa cells occurs on a comparable time scale,[16] the 
cell contents, including endosomes and lysosomes, are generally distributed evenly,[17] and 
there are no grounds to believe this will affect the subcellular distribution of uptaken 
nanoparticles. The lack of overlap between type (2)a green particles and red endo/lysosomes 
(Figure 2b) illustrates that the particles have successfully escaped entrapment within these 
organelles (the coplanar characteristics of green particles, red endo/lysosomes and nucleus 
and their perfect spatial separation are shown in Z-stack images (Figure S1 in the Supporting 
Information), confirming the successful internalisation and cytosol access of nanoparticles. 
Note that nanoparticles present in cytosol are characteristically punctate in appearance; the 
perfect overlap shown in Figure 2a and Figure S1c of green particles and red endo/
lysosomes with type (2)b and type (2)c nanoparticles indicates endo/lysosomal entrapment 
of particles.
Initially, one may expect that a higher degree of amination, equating to a more potent pH-
buffering ability, would translate into more effective escape from the endo/lysosomal 
pathway. Significantly, however, it was found that only the lowest mol% of aminated MSNs 
(1 mol%, type (2)a) were effective in this (Figure 2 and Figure S1 in the Supporting 
Information). To examine this further, the ζ potentials of the particles were screened across a 
broad pH range (Figure 3; the interior of an endosome is known to be acidic, pH≈6, 
becoming more so with fusion/maturation to lysosomes, pH≈4[18]). We define here as 
“charging capacity” the ζ-potential change between pH 4.1 and pH 7.1 (the shaded window 
in Figure 3). Significantly, 1 mol%, (2)a, and 10 mol%, (2)c, of aminated MSNs 
demonstrated the highest and the lowest charging capacities, respectively, among the three 
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type (2) particles. A higher degree of surface amination (substitution of particle silanol 
groups pKa, ≈6.7, with primary APTES amine, pKa≈10.6)[19] specifically brought with it a 
progressive shift of particle pI towards higher values. Intimately associated with this was a 
progressive decrease in the magnitude of charging capacity within the pH window of interest 
(pH 4.1–7.1; see Figure 3). We suggest here that it was exactly this magnitude of particle 
charging that was dominant in triggering endo/lysosomal escape.
This optimal 1 mol% composition was subsequently mapped across particles decorated with 
different basic moieties. Type (3) particles bore surface imidazole groups; type (4) particles 
contained both primary amine and imidazole moieties on the surface; whereas particle type 
(5) possessed both carboxyl and imidazole groups (Figure 1). The successful introduction of 
each functional group was confirmed by tracking ζ-potential change (an accepted method of 
distinguishing nanoparticle surface modifications;[20] Table S1 in the Supporting 
Information) and FTIR following each reaction step (Figure S2 in the Supporting 
Information).
The specific ζ-potential changes of these particles are summarised in Figure 4. As expected, 
due to the absence of a basic function, native FITC-MSNs, type (1), demonstrated the lowest 
charging capacity within this low pH window (30 mV; it is likely that the secondary amine 
functions present in the FITC dye itself were responsible for the charging that was 
observed). For basic nanoparticles, consideration of the functional group pKa 
(APTES>histidine primary amine>imidazole>histidine imidazole>histidine 
carboxyl),[19a,21] allowed prediction of increasing pI in the order (5)<(3)<(4)<(2)a, a trend 
which was experimentally confirmed (Figure 4). Most significant here was the fact that type 
(4) particles had a pI located at the centre of the pH window of interest (≈pH 5.7) and 
accordingly exhibited the greatest charging capacity (the charging capacities of other 
particles fell as their pI’s moved away from this central point).
The uptake and subcellular distribution characteristics of these nanoparticle formulations 
(where yellow indicates a co-localisation of MSNs and endo/lysosomes) are summarised in 
Figure 5 and Figure S3 in the Supporting Information where it is evident that particles 
without possession of a basic moiety, type (1), were endo/lysosomally trapped. 
Significantly, the most charge sensitive particles, type (4), readily accessed the cell cytosol, 
but only if cationisation was marked in the pH range 4.1–7.1. Particle types (3) and (5), 
though exhibiting a large (>40 mV) charge change did not access the cytosol, presumably 
because cationisation, and thus association with the anionic membrane, even at pH 4.1, was 
limited (ζ potentials at pH 4.1 were (10.0±0.2) mV and (1.4±0.2) mV, respectively, 
compared to (29.4±0.2) mV for type (4)).
The uptake pathway of nanoparticles that were ultimately able to access the cell cytosol 
(type 2(a) and type (4)) can be resolved through co-localisation confocal studies at specific 
timeframes. After a 30 min incubation (that typical of early endosome confinement),[22] the 
particles indeed have shown no localisation within late endosomes/lysosomes (Figure S4a 
and c in the Supporting Information, stained with LysoTracker Red).[23] After 5 h, however, 
the particles were clearly entirely located within these locations, see Figure S4b and d in the 
Supporting Information—noting a perfect overlap between green nanoparticles and 
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LysoTracker red. It is, thus, clear that the particles accessed the cell cytosol through the 
expected endocytotic pathway, having been taken up within 30 min (Figure S4 in the 
Supporting Information), ultimately localising in lysosomes after some 5 h, prior to escape 
into the cell cytosol (Figure 6), which occurred within 24 h.
In a relatively simple consideration of functional group surface density and pKa, it was, thus, 
possible to demonstrate the importance of MSN surface charge profile (a substantial >40 
mV change in ζ potential) and cationisation in facilitating escape from default endo/
lysosomal entrapment following endocytosis. Our observations were consistent with 
particles initially passing into early endosomes (pH≈6.3,[18,24] where some retain a negative 
net charge). Maturation into late endosomes (pH≈5–6),[18,24] confirmed by the overlap of 
LysoTracker Red and particle emission[23] occurred after 5 h. Eventual fusion with 
lysosomes (pH≈4.6–5)[18,24] was followed by a surge in protonation/cationisaton, and 
osmotic pressure that resulted in rupturing and cytosolic release (Figure 2b, Figure 5c and 
Figure 6). The Z-stack analysis, location specific staining and control experiments 
unequivocally confirm cytosol access. In the next section, we utilise this ability to control 
subcellular nanoparticle localisation in triggering cell death.
Yeast cytochrome c (Cyt c)-induced programmed cell death
As noted earlier, several approaches to facilitate the delivery of cytochrome c to cells in an 
effort to effect programmed cell death have been reported. These have included the 
incubation of loaded nanoparticles (carbon nanotubes or MSNs),[3a,b,4a] pH-responsive 
polyionic micelles,[13b] or membrane penetration peptide-containing liposomes.[2b] The 
observations made across these works are highly varied; in some cases no toxic effects have 
been noted, even at comparatively high doses (750 pgcell−1, more than five-fold higher than 
used in this work—see below) for which the protein supposedly enjoys cytosol access.[4a]
Herein, a number of cytochrome, bovine serum albumin (BSA) or lysozyme labelled MSNs 
were prepared using a range of linker chemistries (post grafted) through standard 
carbodiimide chemistry (particle types (6) to (11), Figure 7).[25] As the triggering of 
apoptosis requires the activation of cytosolic caspase by cytochrome c, all particles were 
designed using the cytosol-accessing surface chemistry detailed in the previous section by 
conjugating proteins onto 1 mol% primary amine modified particles and keeping the surface 
protein at a very low level (87.5 pmolmg−1, with a protein to amine molar ratio of <0.1%), 
such that the particle surface charge profiles, previously identified as being key to enabling 
subsequent endo/lysosomal escape, were unchanged. For type (7) and (11), note that the 
successful low-level protein modification was qualitatively confirmed by a BCA assay 
(shown in Figure S5 in the Supporting Information) and the charging/escape characteristics 
(charging capacity >40 mV with cationisation) of the nanoparticles remained after 
modification (see the tabulated summary in Figure 7). The exception was type (6) particles 
bearing 10 mol% surface carboxyl groups, which were used as negative controls (i.e., 
particles remained endo/lysosomally entrapped). MSNs with a higher cytochrome dose (type 
(8), 41 nmolmg−1 MSNs) but lacking endo/lysosomal escape capability were also produced 
to further examine the necessity of cytosolic access of cytochrome c to induce apoptosis. 
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Notably, the protein was attached to particle types (6), (7), (8) and (11) through an 
uncleavable APTES linker.
Acid-responsive hydrazine, type (9),[26] and redox-responsive disulfide, type (10),[27] 
chemistries were also used to create cleavable protein linkers in order to examine the 
potential importance of retaining the protein at the particle surface on its physiological 
activity. Particle chemical formulations were characterised by ζ-potential and FTIR changes 
following each reaction step (Table S1 and Figure S2 in the Supporting Information). Note 
that, since the low protein loadings fall below the threshold of FTIR, ratiometric BCA 
assays were employed to determine and semi-quantify protein presence. Importantly, the 
protein surface density (Figure S5 in the Supporting Information) on all the biomodified 
nanoparticles was kept consistent across the investigated samples unless otherwise stated.
In line with the previously identified importance of nano-particle charging capacity, protein-
modified particles (7), (9), (10) and (11) exhibited facile cytosol access whilst those of (6) 
and (8) did not (Figure 7 and Figure S6 in the Supporting Information). The physiological 
effects of these particles on HeLa cells (incubated at 200 μg mL−1 for 24 h) were examined 
using propidium iodide (PI), a dead cell stain (the percentage of cells undergoing 
programmed cell death was determined from the ratio of PI positive and negative cells), and 
summarised in Figure 8a and Table 1. The first point to note is that native FITC-MSNs, type 
(1), exhibited low cytotoxicity at doses up to 200 μg mL−1, comparable to nanoparticle-free 
cell controls (percentage of dead cells (2.1±0.6)% and (2.9±1.6)%, respectively). Particles 
capable of effective endo/lysosomal escape but without the appended cytochrome, type (2)a, 
exhibited slightly increased cellular toxicity (13.9±2.5)%. Most striking were the 
observations made with escapable cytochrome c functionalised particles, type (7), where cell 
death was dramatic (82.1±9.8)% across six repetitions and two separately prepared batches 
of particles, considerably exceeding that observed using microinjection[28] or 
polypeptides[13a] means of introducing this cytochrome. Significantly, this protein dose, 
delivered through an endocytic mechanism, is substantially lower than that used in prior 
work and represents the highest efficacy, in terms of cell death, reported to date.[4a]
Entry of a cell into an apoptotic phase is associated with a series of caspase cascades and 
subsequent membrane inversion.[29b] A caspase 3/7 reporter based on a fluorescent inhibitor 
of caspase (FLICA) technique (Figure 8b);[30] was thus employed to confirm caspase 
activation (at 9 h, before significant cell death had occurred). To further confirm that these 
cells continued to later apoptosis with membrane inversion (and that cell death was not a 
result of any innate native nanoparticle toxicity), the cells were co-stained with Annexin V 
(AnnV), an accepted apoptotic cell indicator that binds to phosphatidyl serine on the outer 
membrane leaflet.[29] As shown in Figure 8c–e, necrotic cells were AnnV-negative/PI-
positive, early apoptotic cells were AnnV-positive/PI-negative and late apoptotic cells were 
AnnV-positive/PI-positive.[29a] These analyses clearly demonstrated that cells treated with 
cytochrome labelled escapable particles, type (7), followed the apoptotic pathway of 
programmed cell death (Figure 8d and e). Figure S7 in the Supporting Information 
summarises the percentages of AnnV-positive cells and PI-positive cells with respect to the 
total cell number. Significantly, the cytochrome labelled particles, type (7), which induced 
the highest percentage of cell death have shown a correspondingly high percentage of 
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AnnV-positive cells (compared to PI-positive cells), confirming, once more, that the cells 
died apoptotically.
An equivalent cell incubation with cytochrome c modified particles incapable of endo/
lysosomal escape, type (6), led to limited cell death (14.9±5.1)%. Similarly, for non-
escapable particles for which cytochrome loading was markedly increased (type (8), 500 
fold to 41 nmol per mg MSNs), cell death was limited (9.8±7.2)%. Cell incubation with an 
equivalent dose (140 pgcell−1) of FITC-labelled cytochrome c alone (not particle bound) led 
to undetectable uptake by confocal fluorescent microscopy and low cell death, comparable 
to controls. To confirm that the observed profound nanoparticle toxicity was not a general 
feature of any protein-decorated MSN capable of accessing the cellular cytosol, that is, it 
was cytochrome c specific, we have examined the effects of an equivalent dose of BSA-
labelled particles capable of endo/lysosomal escape, type (11), where only low toxicity 
levels (15.2±4.0)% were observed (Figure 8a). Another protein control with comparable size 
and pI to cytochrome c, lysozyme (14.3 kDa, pI=11.35), was also investigated showing no 
apoptosis triggering capability (Figure S7 in the Supporting Information). Worth noting 
again here is the fact that these potent particles were associated with uncleavable (amide) 
anchored cytochrome.[31]
As noted previously, loss of free protein or peptide activity through proteolytic degradation 
is well-documented,[1,2b,32] as is the potential stabilising effect of tethering proteins to 
nanoparticles.[2b,33] To examine the potential role of nanoparticle stabilisation of the 
functional protein in this work, we have generated and examined the impact of cellular 
exposure to particle formulations in which the protein was bound through a 
reductively[7b,27] or pH[4b,26]-cleavable linker, particle types (9) and (10). The pH or 
reductant-initiated cleavage of protein from these particles was initially confirmed (Figure 
S5 in the Supporting Information). Significantly, these particles, though exhibiting high 
levels of charge change and cytosol access (see Figure 7, Table 1 and Figure S6 in the 
Supporting Information), induced only limited degrees of cell death, (25.5±4.1)% and 
(20.1±1.1)%, respectively, consistent with the detrimental effects of rapid proteolytic 
degradation of released cytochrome and, consequently, a markedly reduced efficiency of 
caspase cascade triggering.[1b,13a,32,34] These observations demonstrate the importance of 
MSN confinement in stabilising the cytochrome against degradation (by either local pH as 
the particle moves through the endosomal pathway or cytosolic proteases once cytosol 
access is finally secured).
Conclusion
The development of efficient therapies based on proteins, protein fragments or antibodies 
requires that these molecules are efficiently and safely delivered and exposed to the cellular 
machinery on which they are designed to operate. The profoundly low membrane 
permeability and stability in the face of acidified environments or active proteases is, very 
commonly, prohibitively limiting. Herein, we have systematically investigated the 
importance of surface potential and cationisation in mediating the effective access of MSNs 
to the cytosol of human cancer cells through a careful engineering of particle pI by tracking 
modified particles as they were transported through late endosomes, lysosomes and finally 
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into the cytosol with confocal microscopy. In doing so, we have shown that this was most 
effective when ζ-potential changes exceeded 40 mV (see Table 1) and noted that these 
modified particles demonstrated low native cytotoxic responses in vitro. The 12 kDa 
mitochondrial cytochrome, cytochrome c, is known to be effective in initiating the activation 
of a “caspase cascade” and, subsequently, cell death if cytosol access is achieved without 
rapid degradation. On incorporating a low dose (140 pgcell−1) of this protein onto the 
surface of optimised cytosol-accessing fluorescent MSN formulations it was possible to 
induce programmed cell death with remarkable efficacy (>80%) in human cervical 
carcinoma HeLa cells, as monitored using an apoptosis-specific Annexin V assay and a 
caspase reporter. This cell suicide pathway, mechanistically common to all mammalian 
cells,[8] was effected here by both the cytosolic accessibility of the nanoparticle payload and 
the conformational stability afforded to the cytochrome through its surface confinement 
(particles have a stabilising effect and prevent tethered proteins from proteolytic 
degradation).[2b] To the best of our knowledge, the delivery mechanism outlined herein is 
without precedent and we believe the work to be highly relevant to the development of 
nanoparticle-based therapies generally.
Experimental Section
The native luminescent MSNs are prepared by co-condensing tetraethyl orthosilicate 
(TEOS) and aminopropyltriethoxysilane (APTES) with templating cetyltrimethylammonium 
bromide (CTAB). The as-synthesised internally aminated MSNs are subsequently coupled 
with N-hydroxysuccinimide (NHS)-fluorescein to obtain internally luminescent MSNs. 
Three different mol % of APTES are post-grafted onto native FITC-MSNs to produce type 
(2) particles (1 mol%, 5 mol% and 10 mol% with respect to TEOS; mol % calculated from 
the molar percentage ratio of amine functionalities with respect to TEOS during the reaction 
steps). Type (3) particles are synthesised by post-carboxylation of type (2)a MSNs and 
subsequent N-(3-dimethylaminopropyl)-N′-ethylcarbodiimide (EDC) and NHS-promoted 
histamine conjugation. A substitution of histamine with histidine generates type (5) 
particles. Direct histidine conjugation onto type (2)a particles generates (4) bearing surface 
primary amine and imidazole groups. Type (6) particles are prepared by carboxylating 10 
mol % aminated MSNs followed by 87.5 pmolmg−1 MSNs of cytochrome coupling. The 
same proportion of cytochrome c or BSA (87.5 pmolmg−1 MSNs) is coupled onto 1 mol% 
primary amine modified MSNs, to yield particle types (7) and (11), respectively. A higher 
amount of cytochrome c (41 nmolmg−1 MSNs) is coupled to 0.5 mol % primary amine 
modified MSNs to prepare particle type (8). For the preparation of particles with acid-
responsive protein linkers, native FITC-MSNs are aldehyde modified by post-grafting 
triethoxysilylbutyraldehyde followed by nucleophilic addition of succinic dihydrazide. The 
resulting hydrazone modified MSNs are then post-functionalised with APTES at 1 mol% 
and conjugated with cytochrome c, to generate particle type (9). Disulfide linked particles 
(10) are prepared by coupling cystamine to carboxylated MSNs followed by 1 mol % of 
APTES grafting and cytochrome attachment. Particle modifications were tracked at each 
step using ζ potential and FTIR spectroscopy; for these, further details of concentrations of 
each reactant, the specific reaction conditions and cellular experiments, see the Supporting 
Information.
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Refer to Web version on PubMed Central for supplementary material.
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Figure 1. 
Structural representations of (1) native FITC-MSNs; (2) primary amine modified MSNs (a, 
b and c having 1, 5 and 10 mol% amination respectively); (3) 1 mol% imidazole modified 
MSNs; (4) 1 mol% primary amine and imidazole co-modified MSNs; (5) 1 mol % imidazole 
and carboxyl co-modified MSNs. Functional group pKa values and a summary of 
hydrodynamic diameter (dhyd), polydispersity index (PDI), ζ potential at two relevant pH 
boundaries, charging capacity and cytosol accessibility are also included. Data indicates 
surface modifications only have minor effects on particle hydrodynamic size and 
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distribution (PDI values <0.3 across all particle types indicate excellent particle size 
distribution and colloidal stability). A typical TEM image of MSNs (95±8) nm is also shown 
in the first row (scale bar 100 nm). Note that DLS measures sizes based on the solvation 
state of particles in solution, resulting in larger values than that obtained from TEM.
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Figure 2. 
Merged representative confocal fluorescent images of HeLa cells 24 h after incubation 
(≈3×103 cells with 200 μg mL−1 of MSNs) with a) 5 mol% primary amine modified MSNs, 
type (2)b, and b) 1 mol% primary amine modified MSNs, type (2)a. Spectrally resolved 
components of the circled regions are magnified and shown below each image. The images 
shown are entirely representative of the behaviour observed across the population of cells 
for each given particle type. The yellow in (a) indicates co-localisation of MSNs and endo/
lysosomes. This localisation is confirmed on unmixing the particle and lysomal emissions 
(note the near perfect overlap of green particles and red lysosomes). For 1 mol% particles 
(b), subcellular distribution is markedly different and there is very little alignment of particle 
and lysosome emission. The ability of these particular particles to access the cytosol is 
additionally confirmed by Z-stack analysis, additional location specific staining, and control 
experiments with different exterior chemistries and protein appendages (Figure S1 in the 
Supporting Information).
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Figure 3. 
Particle ζ potentials as a function of solution pH. Graph data points are the mean zeta values 
across five repetitions. The shaded area highlights the ζ-potential changes associated with 
the particles moving between pH 4.1 and pH 7.1. The charging capacities of each particle 
type are stated top right. A higher degree of amination pushes the particle pI towards higher 
values and the associated charging capacity within the window drops.
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Figure 4. 
Particle ζ potentials as a function of solution pH. Graph data points are the mean zeta values 
across five repetitions. The central shaded area highlights the ζ-potential changes across the 
pH 4.1–7.1 window. The charging capacities of each particle type are stated. pI increases 
through the particle series according to (5)<(3)<(4)<(2)a.
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Figure 5. 
Merged confocal fluorescent images of HeLa cells after 24 h incubation (≈3×103 cells 
incubated with 200 μg mL−1 of MSNs) confirming that only 1 mol% primary amine and 
imidazole co-modified MSNs, type (4), are capable of escape into the cytosol. For the 
spectrally resolved components see Figure S3 in the Supporting Information. Images from 
(a) to (d) are the corresponding characteristic results associated with type (1), type (3), type 
(4) and type (5) particles, respectively. Yellow colour represents co-localised MSNs (green) 
and endo/lysosomes (red). Arrows indicate MSNs that have escaped endo/lysosomal 
entrapment. The images shown are entirely representative of the behaviour observed across 
the population of cells for each given particle type.
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Figure 6. 
A schematic model of the endo/lysosomal escape process. The red pH profile shown is that 
of the optimised escapable nanoparticle, type (4). Particles initially exhibit a negative 
surface charge at pH≈7.4. After endocytosis, they are entrapped in acidic early endosomes 
(pH≈6.3) and then late endosomes (pH≈5–6), during which their surface charge becomes 
increasingly positively charged. When late endosomes fuse into lysosomes (pH≈4.6–5) the 
particle surface is highly cationic and escape occurs (see arrow indications in Figure 5c).
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Figure 7. 
Structural representations of (6) cytochrome c (Cyt c) labelled MSNs with 10 mol% 
carboxyl coating; (7) cytochrome c labelled MSNs with 1 mol % primary amine coating; (8) 
cytochrome c labelled MSNs with 0.25 mol% primary amine coating; (9) acid-responsive 
cytochrome c labelled MSNs with 1 mol% primary amine coating; (10) reductant cleavable-
responsive cytochrome c labelled MSNs with 1 mol% primary amine coating; (11) BSA or 
lysozyme labelled MSNs with 1 mol% primary amine coating. A summary of hydrodynamic 
diameter (dhyd), polydispersity index (PDI), ζ potential at two relevant pH boundaries, 
charging capacity and cytosol accessibility is also included for each particle type.
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Figure 8. 
a) Haemocytometer data summarising the percentage of cells undergoing programmed cell 
death (determined from the ratio of PI positive and negative cells) as effected by dosing with 
different nanoparticle formulations as labelled (each dosage ≈3×103 cells with 200 μg mL−1 
MSNs, 24 h incubation). Data shown are the results of three repetitions across two 
separately prepared batches of particles (6 repetitions in total and an average of 250 cells 
analysed). * represents statistically significant results with P<0.05; ** with P<0.005. b) 
Merged confocal image with bright field, blue nucleus (Hoechst stained), green escapable 
cytochrome labelled type (7) particles and red caspase 3/7 at 9 h (at this time period, partial 
particle escape was observed and accordingly a caspase cascade initiation would be 
expected prior to high levels of cell death), confirming particle triggered caspase cascade, 
the precursor to apoptotic cell death. Confocal fluorescent images show HeLa cell 
suspensions after 24 h incubation with c) particle type (2)a and d), e) particle type (7). AnnV 
(blue) binds phosphatidylserine on the outer membrane leaflet of apoptotic cells and 
indicates the cell boundary within which MSNs are clearly internalised (green). The dead 
cell indicator, PI (red), binds to nucleic acids (nucleus). c) Necrotic cells are AnnV-
negative/PI-positive showing only red nucleus; d) early apoptotic cells are AnnV-
positive/PI-negative, showing only blue membrane stain; e) late apoptotic cells are AnnV-
positive/PI-positive[29] showing both red nucleus and blue membrane stain. The images 
shown are entirely representative of the behaviour observed across the population of cells 
for each given particle type.
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Table 1
Summary of programmed cell death (24 h, 200 μg mL−1 dose).[a]
MSN Type Charging Capacity 
>40 mV
Highly Cationic at 
pH 4.1
Endosomal Escape Permanently 
Immobilised Cyt c
Programmed Cell Death
(1) x x x x x
(2)a ✓ ✓ ✓ x x
(6) ✓ x x ✓ x
(7) ✓ ✓ ✓ ✓ ✓
(8) x ✓ x ✓ x
(9) ✓ ✓ ✓ x x
(10) ✓ ✓ ✓ x x
(11) ✓ ✓ ✓ x x
[a]✓=Presence of MSNs properties; x=absence of MSNs properties.
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